<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer - Diaz‐Nieto, R - 2013 | Cochrane Library</title> <meta content="Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer - Diaz‐Nieto, R - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008415.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer - Diaz‐Nieto, R - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008415.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008415.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer" name="citation_title"/> <meta content="Rafael Diaz‐Nieto" name="citation_author"/> <meta content="Royal Free Hospital" name="citation_author_institution"/> <meta content="rafadiaznieto@hotmail.com" name="citation_author_email"/> <meta content="Rafael Orti‐Rodríguez" name="citation_author"/> <meta content="Royal Free Hospital" name="citation_author_institution"/> <meta content="Marc Winslet" name="citation_author"/> <meta content="Royal Free Hospital and Medical School" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD008415.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/09/02" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008415.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008415.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008415.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antineoplastic Agents [*therapeutic use]; Disease‐Free Survival; Fluorouracil [therapeutic use]; Gastrectomy [methods]; Lymph Node Excision; Postoperative Care [methods]; Randomized Controlled Trials as Topic; Stomach Neoplasms [*drug therapy, mortality, *surgery]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008415.pub2&amp;doi=10.1002/14651858.CD008415.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="i9CklieH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008415\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008415\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008415.pub2",title:"Post\\u2010surgical chemotherapy versus surgery alone for resectable gastric cancer",firstPublishedDate:"Sep 2, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008415.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008415.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008415.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008415.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008415.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008415.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008415.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008415.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008415.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008415.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2086 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008415.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-sec1-0006"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/appendices#CD008415-sec1-0012"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/table_n/CD008415StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/table_n/CD008415StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information#CD008415-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Rafael Diaz‐Nieto</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information#CD008415-cr-0003">Rafael Orti‐Rodríguez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information#CD008415-cr-0004">Marc Winslet</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information/en#CD008415-sec1-0014">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 02 September 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008415.pub2">https://doi.org/10.1002/14651858.CD008415.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008415-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008415-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008415-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008415-abs-0001" lang="en"> <section id="CD008415-abs1-0001"> <h3 class="title" id="CD008415-abs1-0001">Background</h3> <p>For gastric cancer surgery is the mainstay treatment. Chemotherapy seems to improve the survival results. But chemotherapy is not a complication‐free therapy and its role has been questioned by some trials. </p> </section> <section id="CD008415-abs1-0002"> <h3 class="title" id="CD008415-abs1-0002">Objectives</h3> <p>To determine whether post‐surgical chemotherapy should be used routinely in resectable gastric cancer. </p> </section> <section id="CD008415-abs1-0003"> <h3 class="title" id="CD008415-abs1-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i>, MEDLINE, EMBASE, and Science Citation Index Expanded (July 2013). </p> </section> <section id="CD008415-abs1-0004"> <h3 class="title" id="CD008415-abs1-0004">Selection criteria</h3> <p>Randomised controlled trials (RCT) comparing post‐surgical chemotherapy versus surgery alone for resectable gastric cancer. </p> </section> <section id="CD008415-abs1-0005"> <h3 class="title" id="CD008415-abs1-0005">Data collection and analysis</h3> <p>Two authors independently assessed trials for inclusion and independently extracted the data. We analysed the data with both the fixed‐effect and the random‐effects models using the RevMan analysis software. We calculated the hazard ratio (HR) with 95% confidence interval (CI) based on intention‐to‐treat or available case analysis. </p> </section> <section id="CD008415-abs1-0006"> <h3 class="title" id="CD008415-abs1-0006">Main results</h3> <p>The authors identified 34 studies (7824 patients) reporting overall survival (OS) and only 15 reporting disease free survival (DFS) as well. Post‐surgical chemotherapy showed an improvement in OS (HR 0.85; 95% CI 0.80 to 0.90) and an improvement in DFS (HR 0.79; 95% CI 0.72 to 0.87), although all the trials had a high risk of bias. </p> <p>The planned analysis of quality of life, return to work, and number of hospital admissions was impossible to complete as the outcome data for the analysis were not available from any trials. </p> </section> <section id="CD008415-abs1-0007"> <h3 class="title" id="CD008415-abs1-0007">Authors' conclusions</h3> <p>Post‐surgical chemotherapy should be used routinely for resectable gastric cancer where possible. Further RCTs are needed to determine the role at each stage of disease. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008415-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008415-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008415-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008415-abs-0005" lang="en"> <h3>Chemotherapy after surgery versus surgery alone for stomach cancer</h3> <p>Stomach cancer is the second leading cause of cancer‐related death worldwide. Surgery is the only curative treatment offered to patients suffering from this cancer. Survival rates, however, are still poor. Chemotherapy given after surgery has been developed in order to improve these results. We identified 34 trials with 7824 patients which randomised patients to surgery with post‐surgical chemotherapy versus surgery alone. The group who received chemotherapy had a survival benefit and improvement in disease free survival (15% and 21%, respectively), although all the trials had a high risk of bias. There was no significant difference due to the stage of disease or the chemotherapy agent used. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008415-sec1-0007" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-sec1-0007">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-sec1-0022">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008415-sec1-0007"></div> <h3 class="title" id="CD008415-sec1-0008">Implications for practice</h3> <section id="CD008415-sec1-0008"> <p>Post‐surgical chemotherapy should be use for patients with resectable gastric cancer following the results of this review, however it is important to note that some of the included trials present limitations and definitive assessments on this topic may be delayed until future trials are properly developed. </p> </section> <h3 class="title" id="CD008415-sec1-0009">Implications for research</h3> <section id="CD008415-sec1-0009"> <p>Further low bias‐risk trials are necessary to determine wether post‐surgical chemotherapy should be used routinely in every stage of gastric cancer. The chemotherapy agent and the standard regimen and duration are still topics that require clarification. Quality of life and cost‐effectiveness represent two important topics that should be considered in future studies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008415-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008415-sec1-0001"></div> <div class="table" id="CD008415-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Post‐surgical chemotherapy compared to surgery alone for resectable gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Post‐surgical chemotherapy compared to surgery alone for resectable gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with resectable gastric cancer<br/> <b>Settings:</b> <br/> <b>Intervention:</b> Post‐surgical chemotherapy<br/> <b>Comparison:</b> Surgery alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall Survival (OS)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.85</b> <br/> (0.80 to 0.90) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7523<br/> (34 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Disease Free Survival</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.79</b> <br/> (0.72 to 0.87) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4133<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> Very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD008415-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subgroup analysis for resectable gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Subgroup analysis for resectable gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with resectable gastric cancer<br/> <b>Settings:</b> <br/> <b>Intervention:</b> Subgroup analysis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased OS ‐ 5‐FU based chemotherapy OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.88</b> <br/> (0.83 to 0.94) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5694<br/> (28 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased OS ‐ Platinum‐based chemotherapy OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.9</b> <br/> (0.81 to 1) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1504<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased DFS ‐ 5‐FU based chemotherapy DFS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.86</b> <br/> (0.78 to 0.95) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2944<br/> (13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased DFS ‐ Platinum‐based chemotherapy DFS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.89</b> <br/> (0.75 to 1.06) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>969<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> Very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD008415-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Subgroup analysis for resectable gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Subgroup analysis for resectable gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with resectable gastric cancer<br/> <b>Settings:</b> <br/> <b>Intervention:</b> Subgroup analysis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stage OS analysis ‐ T1/2 OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.86</b> <br/> (0.71 to 1.05) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1146<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stage OS analysis ‐ T3/4 OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.66</b> <br/> (0.41 to 1.08) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1008<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lymph node mets analysis ‐ N‐ OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.74</b> <br/> (0.41 to 1.33) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>402<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lymph node mets analysis ‐ N+ OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.78</b> <br/> (0.67 to 0.91) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>877<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> Very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008415-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-sec1-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-sec1-0018">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD008415-sec1-0002"></div> <section id="CD008415-sec2-0001"> <h3 class="title" id="CD008415-sec2-0001">Description of the condition</h3> <p>Gastric cancer is an important disease worldwide and it represents the second leading cause of cancer‐related death in the world (<a href="./references#CD008415-bbs2-0053" title="Cancer Research UK. Stomach cancer. http://www.cancerresearchuk.org/cancer‐info/cancerstats/world/stomach‐cancer‐world/ (accessed 03 December 2012). ">CRUK 2012</a>). In 2008, 3052 deaths due to gastric cancer were reported in the United Kingdom and 6450 in the United States of America (<a href="./references#CD008415-bbs2-0067" title="International Agency for Research on Cancer (WHO). Estimated cancer incidence, mortality, prevalence and disability‐adjusted life years (DALYs) worldwide in 2008. http://globocan.iarc.fr/ (accessed 03 December 2012). ">GLOBOCAN 2008</a>). </p> <p>Adenocarcinoma represents 90% of all gastric cancers. It has been classified as well‐differentiated or intestinal type, and undifferentiated or diffuse type (<a href="./references#CD008415-bbs2-0052" title="CrewKD , NeugutAI . Epidemiology of gastric cancer. World Journal of Gastroenterology2006;12(3):354‐62. [PUBMED: 16489633] ">Crew 2006</a>). Other histological types like epidermoid tumours or stromal tumours have a significantly lower incidence and a very different clinical course, management and prognosis than adenocarcinoma. </p> <p>Surgical resection is, to date, the main management and the only curative treatment that can be offered to patients with gastric cancer (<a href="./references#CD008415-bbs2-0050" title="AlbertsSR , CervantesA , van deVeldeCJ . Gastric cancer: epidemiology, pathology and treatment. Annals of Oncology2003;14 Suppl 2:ii31‐6. [PUBMED: 12810455] ">Alberts 2003</a>). Partial gastric resection or total gastrectomy are the surgical options commonly performed and both try to maximize elimination of tumour, with no significant difference in terms of survival when they are compared (<a href="./references#CD008415-bbs2-0051" title="BozzettiF , MarubiniE , BonfantiG , MiceliR , PianoC , GennariL . Subtotal verus total gastrectomy for gastric cancer: five‐year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Annals of Surgery1999;230(2):170‐8. ">Bozzetti 1999</a>). Extended lymphadenectomy procedures aim to eradicate any residual disease or tumour cell progression through lymph nodes but the role of these procedures is controversial and there is an important disparity of results in the demonstration of real improvement in survival and the morbidity of this additional therapy (<a href="./references#CD008415-bbs2-0082" title="McCullochP , NitaME , KaziH , Gama‐RodriquesJ . Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD001964.pub2] ">McCulloch 2003</a>; <a href="./references#CD008415-bbs2-0083" title="MemonMA , SubramanyaMS , KhanS , HossainMB , OslandE , MemonB . Meta‐Analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Annals of Surgery2011;253(5):900‐11. ">Memon 2011</a>). </p> <p>The role of chemotherapy remains unclear and the presence in the literature of at least seven meta‐analyses regarding this topic support this notion (<a href="./references#CD008415-bbs2-0060" title="EarleCC , MarounJA . Adjuvant chemotherapy after curative resection for gastric cancer in non‐Asian patients: revisiting a meta‐analysis of randomised trials. European Journal of Cancer1999;35(7):1059‐64. [PUBMED: 10533448] ">Earle 1999</a>; <a href="./references#CD008415-bbs2-0071" title="HermansJ , BonenkampJJ , BoonMC , BuntAM , OhyamaS , SasakoM , Van deVeldeCJ . Adjuvant therapy after curative resection for gastric cancer: meta‐analysis of randomized trials. Journal of Clinical Oncology1993;11(8):1441‐7. ">Hermans 1993</a>; <a href="./references#CD008415-bbs2-0074" title="HuJK , ChenZX , ZhouZG , ZhangB , TianJ , ChenJP , et al. Intravenous chemotherapy for resected gastric cancer: meta‐analysis of randomized controlled trials. World Journal of Gastroenterology2002;8(6):1023‐8. [PUBMED: 12439918] ">Hu 2002</a>; <a href="./references#CD008415-bbs2-0076" title="JeungHC , RhaSY , ShinSJ , AhnJB , RohJK , ParkCH , et al. Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials. Cancer Chemotherapy and Pharmacology2009;63(5):919‐27. [PUBMED: 18712389] ">Jeung 2009</a>; <a href="./references#CD008415-bbs2-0080" title="MariE , FlorianiI , TinazziA , BudaA , BelfiglioM , ValentiniM , et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta‐analysis of published randomised trials. Annals of Oncology2000;11(7):837‐43. [PUBMED: 10997811] ">Mari 2000</a>; <a href="./references#CD008415-bbs2-0087" title="ObaK , MoritaS , TsuburayaA , KoderaY , KobayashiM , SakamotoJ . Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta‐analysis of centrally randomized controlled clinical trials in Japan. Journal of Chemotherapy2006;18(3):311‐7. [PUBMED: 17129844] ">Oba 2006</a>; <a href="./references#CD008415-bbs2-0089" title="PaolettiX , ObaK , BurzykowskiT , MichielsS , OhashiY , PignonJP , et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta‐analysis. JAMA2010;303(17):1729‐37. ">Paoletti 2010</a>). Chemotherapy and surgery can be combined in different regimes as chemotherapy can be administrated previous to or after surgery. Commonly, it is accepted as 'adjuvant chemotherapy' if it is administrated after surgery, 'neoadjuvant chemotherapy' when it takes place previous to surgery, and 'perioperative chemotherapy' when both neoadjuvant and adjuvant chemotherapy are combined. However, sometimes this is unclear in some trials, hence we refer to our intervention as post‐surgical chemotherapy in order to avoid confusion. </p> <p>Surgery alone is described as adequate treatment for early stage tumours (<a href="./references#CD008415-bbs2-0077" title="KimJP , KwonOJ , OhST , YangHK . Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Annals of Surgery1992;216(3):269‐78; discussion 278‐9. [PUBMED: 1417176] ">Kim 1992b</a>), and it is commonly accepted that chemotherapy should be given to those patients with an advanced stage tumour (<a href="./references#CD008415-bbs2-0099" title="WagnerAD , GrotheW , BehlS , KleberG , GrotheyA , HaertingJ , et al. Chemotherapy for advanced gastric cancer. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD004064.pub2] ">Wagner 2005</a>). This is supported by recent publications (<a href="./references#CD008415-bbs2-0097" title="SunP , XiangJB , ChenZY . Meta‐analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. British Journal of Surgery2009;96(1):26‐33. ">Sun 2009</a>) but other well‐defined trials and older meta‐analyses do not share these results (<a href="./references#CD008415-bbs2-0010" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of National Cancer Institute2008;100(6):388–98. ">Di Costanzo 2008</a>; <a href="./references#CD008415-bbs2-0071" title="HermansJ , BonenkampJJ , BoonMC , BuntAM , OhyamaS , SasakoM , Van deVeldeCJ . Adjuvant therapy after curative resection for gastric cancer: meta‐analysis of randomized trials. Journal of Clinical Oncology1993;11(8):1441‐7. ">Hermans 1993</a>). Secondly, early recurrence and disease free survival period are not described in some of the current reviews. Finally, morbidity and mortality related to chemotherapy have not been properly reported and they both may modify the recommendation for chemotherapy. </p> <p>Analysis of old and new trials comparing chemotherapy versus surgery alone, once curative resection has been performed, may clarify the role of adjuvant chemotherapy in overall survival and disease free survival in patients with gastric cancer. </p> </section> <section id="CD008415-sec2-0002"> <h3 class="title" id="CD008415-sec2-0002">Description of the intervention</h3> <p>After potentially curative surgical resection for gastric cancer, chemotherapy using a single drug or a combination of drugs may be given (post‐surgical chemotherapy). </p> </section> <section id="CD008415-sec2-0003"> <h3 class="title" id="CD008415-sec2-0003">How the intervention might work</h3> <p>Post‐surgical chemotherapy may remove residual cancer cells or cancer cells in the systemic circulation that surgery cannot remove and which could be the reason for recurrence and death (<a href="./references#CD008415-bbs2-0063" title="EguchiT , KoderaY , NakanishiH , YokoyamaH , OhashiN , ItoY , et al. The effect of chemotherapy against micrometastases and isolated tumor cells in lymph nodes: an in vivo study. In Vivo2008;22(6):707‐12. [PUBMED: 19180995] ">Eguchi 2008</a>). </p> </section> <section id="CD008415-sec2-0004"> <h3 class="title" id="CD008415-sec2-0004">Why it is important to do this review</h3> <p>The treatment options for resectable gastric cancer include resection alone, resection with pre‐surgical and post‐surgical chemotherapy (perioperative chemotherapy), and post‐surgical chemotherapy. The role of gastric resection with pre‐surgical and post‐surgical chemotherapy is being assessed in another Cochrane Review (<a href="./references#CD008415-bbs2-0094" title="SlangerTE , SchwarzbachM , HofheinzR , KienleP , JensenK , KieserM , et al. Perioperative chemotherapy versus primary surgery for locoregionally advanced resectable adenocarcinoma of the stomach, gastroesophageal junction and lower esophagus. Cochrane Database of Systematic Reviews2009, Issue 4. [CENTRAL: CD008107; DOI: 10.1002/14651858.CD008107.pub2] ">Slanger 2009</a>). The role of post‐surgical chemotherapy for gastric cancer in improving patient survival remains unclear. In addition, the use of chemotherapeutic agents is not risk free and they should be used only if justified. Post‐surgical chemotherapy has been found to be effective in the treatment of other cancers such as breast cancer (<a href="./references#CD008415-bbs2-0061" title="Early Breast Cancer Trialists' Collaborative Group (EBCTCG), ClarkeM , CoatesAS , DarbySC , DaviesC , GelberRD , et al. Adjuvant chemotherapy in oestrogen‐receptor‐poor breast cancer: patient‐level meta‐analysis of randomised trials. Lancet2008;371(9606):29‐40. [PUBMED: 18177773] ">EBCTCG 2008</a>; <a href="./references#CD008415-bbs2-0065" title="FergusonT , WilckenN , VaggR , GhersiD , NowakAK . Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews2007, Issue 4. [CENTRAL: CD004421; DOI: 10.1002/14651858.CD004421.pub2] ">Ferguson 2007</a>; <a href="./references#CD008415-bbs2-0081" title="MauriD , PolyzosNP , SalantiG , PavlidisN , IoannidisJP . Multiple‐treatments meta‐analysis of chemotherapy and targeted therapies in advanced breast cancer. Journal of the National Cancer Institute2008;100(24):1780‐91. [PUBMED: 19066278] ">Mauri 2008</a>). However, while some trials seem to support the use of post‐surgical chemotherapy for resectable gastric cancers (<a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a>; <a href="./references#CD008415-bbs2-0089" title="PaolettiX , ObaK , BurzykowskiT , MichielsS , OhashiY , PignonJP , et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta‐analysis. JAMA2010;303(17):1729‐37. ">Paoletti 2010</a>) others do not (<a href="./references#CD008415-bbs2-0059" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of the National Cancer Institute2008;100(6):388‐98. ">Di Costanzo 2008b</a>; <a href="./references#CD008415-bbs2-0074" title="HuJK , ChenZX , ZhouZG , ZhangB , TianJ , ChenJP , et al. Intravenous chemotherapy for resected gastric cancer: meta‐analysis of randomized controlled trials. World Journal of Gastroenterology2002;8(6):1023‐8. [PUBMED: 12439918] ">Hu 2002</a>). The aim of this review was to determine whether post‐surgical chemotherapy improves overall survival and disease free survival in patients with resectable gastric cancer. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008415-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-sec1-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-sec1-0019">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008415-sec1-0003"></div> <p>To determine whether post‐surgical chemotherapy should be used routinely in patients with resectable gastric adenocarcinoma. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008415-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-sec1-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-sec1-0020">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008415-sec1-0004"></div> <section id="CD008415-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008415-sec3-0001"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCT). We excluded quasi‐randomised studies for survival outcomes but included them for evaluation of the adverse effects of chemotherapy, such as anaemia and gastrointestinal toxicity. </p> </section> <section id="CD008415-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Patients undergoing partial or total gastrectomy for gastric cancer, irrespective of the location of the cancer (distal, proximal or oesophagogastric junction). </p> </section> <section id="CD008415-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>Post‐surgical chemotherapy (irrespective of whether a single drug or a combination of drugs were used and the duration of the treatment) versus surgery alone without post‐surgical chemotherapy in patients undergoing partial or total gastrectomy, irrespective of nodal status, whether pancreatosplenectomy was performed, or the presence of microscopic involvement of the resection margins. </p> <p>We excluded trials assessing the following interventions.</p> <p> <ol id="CD008415-lst1-0001"> <li> <p>Combination of pre‐surgical and post‐surgical chemotherapy in patients undergoing resection for gastric cancer. </p> </li> <li> <p>Combination of post‐surgical chemotherapy and radiotherapy in patients undergoing resection for gastric cancer. </p> </li> <li> <p>Combination of post‐surgical chemotherapy and immunotherapy using drugs which have generic immunomodulation potential in patients undergoing resection for gastric cancer. However, we included any trials which used monoclonal antibodies that were targeted against specific proteins in combination with post‐surgical chemotherapy. We only excluded non‐specific immunotherapy, such as interferon or bacillus Calmette‐Guerin (BCG) as it would be difficult to assess the effectiveness of the chemotherapy. </p> </li> </ol> </p> </section> <section id="CD008415-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD008415-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008415-lst1-0002"> <li> <p>Overall survival:</p> <ol id="CD008415-lst2-0001"> <li> <p>hazard ratio.</p> </li> </ol> </li> <li> <p>Disease free survival:</p> <ol id="CD008415-lst2-0002"> <li> <p>hazard ratio.</p> </li> </ol> </li> </ol> </p> </section> <section id="CD008415-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008415-lst1-0003"> <li> <p>Quality of life (however defined by authors).</p> </li> <li> <p>Adverse effects attributed to chemotherapy, such as bone marrow suppression (anaemia, neutropenia, thrombocytopenia grades three and four of the World Health Organization (WHO) classification); gastrointestinal side effects (nausea, vomiting grades three and four of the WHO classification); cardiac toxicity (heart failure); and death related to post‐surgical chemotherapy (<a href="./references#CD008415-bbs2-0100" title="World Health Organization. Handbook for reporting results of cancer treatment. Vol. WHO Offset Publication No. 48, Geneva: World Health Organization, 1979. [http://whqlibdoc.who.int/publications/9241700483.pdf] ">WHO 1979</a>). </p> </li> <li> <p>Number of hospital admissions after discharge.</p> </li> <li> <p>Return to work.</p> </li> </ol> </p> </section> </section> </section> <section id="CD008415-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched the following resources.</p> <section id="CD008415-sec3-0005"> <h4 class="title">Electronic searches</h4> <p> <ul id="CD008415-lst1-0004"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i> (<a href="./appendices#CD008415-sec2-0023">Appendix 1</a>) </p> </li> <li> <p>MEDLINE (1950 to July 2013) (<a href="./appendices#CD008415-sec2-0024">Appendix 2</a>) </p> </li> <li> <p>EMBASE (1980 to July 2013) (<a href="./appendices#CD008415-sec2-0025">Appendix 3</a>) </p> </li> <li> <p>Science Citation Index Expanded (<a href="http://portal.isiknowledge.com/portal.cgi?DestApp=WOS%26Func=Frame" target="_blank">http://portal.isiknowledge.com/portal.cgi?DestApp=WOS&amp;Func=Frame</a>) (1976 to July 2013) (<a href="./appendices#CD008415-sec2-0026">Appendix 4</a>) </p> </li> </ul> </p> </section> <section id="CD008415-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>Reference lists from trials selected by electronic searching were handsearched to identify further relevant trials. Published abstracts from conference proceedings from the United European Gastroenterology Week (published in <i>Gut</i> ), Digestive Disease Week (published in <i>Gastroenterology</i>) and ENT news also were handsearched. </p> <p>In addition, members of the Cochrane Upper Gastrointestinal and Pancreatic Diseases (UGPD) Group and experts in the field were contacted and asked to provide details of outstanding clinical trials and any relevant unpublished materials. We also contacted the Cochrane Ear, Nose and Throat Diseases Group to confirm that our search was comprehensive. </p> <p>The review authors carried out the search independently from each other. Reference lists of identified publications were scanned for additional trials and authors contacted if necessary. In addition, the reference lists of any previous reviews on the subject and the review authors' own files were scanned for relevant studies. No language restrictions were applied. The full text articles of the retrieved trials were reviewed by at least two review authors and the inclusion criteria applied independently. Any differences in opinion about which studies to include in the review were resolved by discussion between the review authors. Possible additional search terms were discussed at one of the conferences where the subject was presented. </p> </section> </section> <section id="CD008415-sec2-0007"> <h3 class="title" id="CD008415-sec2-0007">Data collection and analysis</h3> <section id="CD008415-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>Two authors (RDN and ROR) identified the trials for inclusion, independent of each other. We also listed the excluded trials with the reasons for exclusion in the '<a href="./references#CD008415-sec2-0030" title="">Characteristics of excluded studies</a>' table. </p> </section> <section id="CD008415-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>RDN and ROR extracted the data for the review independently. In addition, we extracted the population characteristics (such as sex, age, type of gastrectomies) and the interventions used in each trial. We clarified any unclear or missing information by contacting the authors of the individual trials. If there was any doubt as to whether the trials shared the same patients, completely or partially (by identifying common authors and centres), we contacted the authors of the trials to establish whether the trial report had been duplicated. We resolved any differences in opinion through discussion. </p> <p>For overall survival and disease free survival, we extracted the logarithm of hazard ratios [ln(HR)] and the standard error (SE) of ln(HR) using the methods described by Parmar et al (<a href="./references#CD008415-bbs2-0090" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. [PUBMED: 9921604] ">Parmar 1998</a>) and the Excel sheet provided by Tierney et al (<a href="./references#CD008415-bbs2-0098" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8:16. [PUBMED: 17555582] ">Tierney 2007</a>). </p> <p>We followed the instructions given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008415-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org. ">Higgins 2008</a>) and the <i>C</i>ochrane Upper GastrointestinaI and Pancreatic Diseases Group Module (<a href="./references#CD008415-bbs2-0066" title="FormanD , DelaneyB , KuipersE , MalthanerR , MoayyediP , GardenerE , et al. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group. In: The Cochrane Library, Issue 2, 2010. Chichester: Wiley‐Blackwell. Updated quarterly. ">Forman 2009</a>). We imputed the standard deviation from P values according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and used the median for the meta‐analysis when the mean was not available. If it was not possible to calculate the standard deviation from P values or confidence intervals, we imputed the standard deviation as the highest standard deviation noted for that group under that outcome. </p> </section> <section id="CD008415-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>According to empirical evidence (<a href="./references#CD008415-bbs2-0078" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine2001;135(11):982‐9. ">Kjaergard 2001</a>; <a href="./references#CD008415-bbs2-0084" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet1998;352(9128):609‐13. ">Moher 1998</a>; <a href="./references#CD008415-bbs2-0092" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>; <a href="./references#CD008415-bbs2-0101" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanGD , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336:601‐5. ">Wood 2008</a>), we assessed the risk of bias in the trials based on sequence generation, allocation concealment, blinding (of participants, personnel and outcome assessors), incomplete outcome data, selective outcome reporting and other sources of bias. We assessed the risk of bias in the trials independently, without masking of the trial names. Quality components were based on the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008415-bbs2-0069" title="GurusamyKS , GluudC , NikolovaD , DavidsonBR . Assessment of risk of bias in randomized clinical trials in surgery. British Journal of Surgery2009;96(4):342‐9. ">Gurusamy 2009</a>; <a href="./references#CD008415-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org. ">Higgins 2008</a>). </p> <section id="CD008415-sec4-0003"> <h5 class="title">Sequence generation</h5> <p> <ul id="CD008415-lst1-0005"> <li> <p>Low risk of bias (the method used is either adequate (e.g. computer‐generated random numbers, table of random numbers) or unlikely to introduce confounding). </p> </li> <li> <p>Uncertain risk of bias (there is insufficient information to assess whether the method used is likely to introduce confounding). </p> </li> <li> <p>High risk of bias (the method used (e.g. quasi‐randomised trials) is improper and likely to introduce confounding). </p> </li> </ul> </p> </section> <section id="CD008415-sec4-0004"> <h5 class="title">Allocation concealment</h5> <p> <ul id="CD008415-lst1-0006"> <li> <p>Low risk of bias (the method used (e.g. central allocation) is unlikely to induce bias in the final observed effect). </p> </li> <li> <p>Uncertain risk of bias (there is insufficient information to assess whether the method used is likely to induce bias in the estimate of effect). </p> </li> <li> <p>High risk of bias (the method used (e.g. open random allocation schedule) is likely to induce bias in the final observed effect). </p> </li> </ul> </p> </section> <section id="CD008415-sec4-0005"> <h5 class="title">Blinding of participants, personnel and outcome assessors</h5> <p> <ul id="CD008415-lst1-0007"> <li> <p>Low risk of bias (blinding was performed adequately, or the outcome measurement is not likely to be influenced by lack of blinding). </p> </li> <li> <p>Uncertain risk of bias (there is insufficient information to assess whether the type of blinding used is likely to induce bias in the estimate of effect). </p> </li> <li> <p>High risk of bias (no blinding or incomplete blinding, and the outcome or the outcome measurement is likely to be influenced by lack of blinding). </p> </li> </ul> </p> </section> <section id="CD008415-sec4-0006"> <h5 class="title">Incomplete outcome data</h5> <p> <ul id="CD008415-lst1-0008"> <li> <p>Low risk of bias (the underlying reasons for missing data are unlikely to make treatment effects depart from plausible values, or proper methods have been employed to handle missing data). </p> </li> <li> <p>Uncertain risk of bias (there is insufficient information to assess whether the missing data mechanism in combination with the method used to handle missing data is likely to induce bias in the estimate of effect). </p> </li> <li> <p>High risk of bias (the crude estimate of effects (e.g. complete case estimate) will clearly be biased due to the underlying reasons for missing data, and the methods used to handle missing data are unsatisfactory). </p> </li> </ul> </p> </section> <section id="CD008415-sec4-0007"> <h5 class="title">Selective outcome reporting</h5> <p> <ul id="CD008415-lst1-0009"> <li> <p>Low risk of bias (the trial protocol is available and all of the trial's prespecified outcomes that are of interest in the review have been reported, or similar). </p> </li> <li> <p>Uncertain risk of bias (there is insufficient information to assess whether the magnitude and direction of the observed effect is related to selective outcome reporting). </p> </li> <li> <p>High risk of bias (not all of the trial's prespecified primary outcomes have been reported, or similar). </p> </li> </ul> </p> </section> <section id="CD008415-sec4-0008"> <h5 class="title">Other bias</h5> <section id="CD008415-sec5-0001"> <h6 class="title">Baseline imbalance</h6> <p> <ul id="CD008415-lst1-0010"> <li> <p>Low risk of bias (there was no baseline imbalance in important characteristics).</p> </li> <li> <p>Uncertain risk of bias (the baseline characteristics were not reported).</p> </li> <li> <p>High risk of bias (there was a baseline imbalance due to chance or due to imbalanced exclusion after randomisation). </p> </li> </ul> </p> </section> <section id="CD008415-sec5-0002"> <h6 class="title">Early stopping</h6> <p> <ul id="CD008415-lst1-0011"> <li> <p>Low risk of bias (sample size calculation was reported and the trial was not stopped or the trial was stopped early by a formal stopping rule at a point where the likelihood of observing an extreme intervention effect due to chance was low). </p> </li> <li> <p>Uncertain risk of bias (sample size calculations were not reported and it is not clear whether the trial was stopped early or not). </p> </li> <li> <p>High risk of bias (the trial was stopped early due to an informal stopping rule or the trial was stopped early by a formal stopping rule at a point where the likelihood of observing an extreme intervention effect due to chance was high). </p> </li> </ul> </p> </section> <section id="CD008415-sec5-0003"> <h6 class="title">Source of funding bias</h6> <p> <ul id="CD008415-lst1-0012"> <li> <p>Low risk of bias (the trial's source(s) of funding was from no parties that might have conflicting interest (e.g. pharmaceutical company)). </p> </li> <li> <p>Uncertain risk of bias (the source of funding was not clear).</p> </li> <li> <p>High risk of bias (the trial was funded by a pharmaceutical company).</p> </li> </ul> </p> <p>We considered trials which were classified as low risk of bias in sequence generation, allocation concealment, blinding, incomplete data and selective outcome reporting as low bias‐risk trials. </p> </section> </section> </section> <section id="CD008415-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>The hazard ratio (HR) was measured with 95% confidence interval (CI) for overall survival and disease free survival. For dichotomous outcomes, the risk ratio (RR) was calculated with 95% CI. For continuous outcomes, we calculated the mean difference (MD) or standardised mean difference (SMD) with 95% CI. The risk difference (RD) was also estimated with 95% CI for dichotomous outcomes and results were only reported if they were different from the RR. </p> </section> <section id="CD008415-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was each patient recruited into the trials.</p> </section> <section id="CD008415-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>Analysis was performed on an 'intention‐to‐treat' basis (<a href="./references#CD008415-bbs2-0086" title="NewellDJ . Intention‐to‐treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology1992;21(5):837‐41. ">Newell 1992</a>) whenever possible. Otherwise, the 'available case' analysis was adopted. </p> </section> <section id="CD008415-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was explored by the Chi² test with significance set at a P value of 0.10, and we measured the quantity of heterogeneity with the I² statistic (<a href="./references#CD008415-bbs2-0072" title="HigginsJPT , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. ">Higgins 2002</a>). An I² statistic of &gt; 50% was considered statistically significant heterogeneity. We calculated the 95% CI for I² using StatsDirect statistical software (<a href="./references#CD008415-bbs2-0096" title="Stats DirectLtd . StatsDirect statistical software. Version 2.7. England: StatsDirect Ltd, 2008. ">StatsDirect 2008</a>). Meta‐regression would have been performed in the presence of at least 10 trials. </p> </section> <section id="CD008415-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>Asymmetry in a funnel plot of trial size against treatment effect was used to assess bias (<a href="./references#CD008415-bbs2-0062" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. ">Egger 1997</a>; <a href="./references#CD008415-bbs2-0079" title="MacaskillP , WalterSD , IrwigL . A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine2001;20(4):641‐54. ">Macaskill 2001</a>). The linear regression approach described by Egger et al was performed to determine the funnel plot asymmetry (<a href="./references#CD008415-bbs2-0062" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. ">Egger 1997</a>). </p> </section> <section id="CD008415-sec3-0015"> <h4 class="title">Data synthesis</h4> <p>The meta‐analyses was performed according to the recommendations of The Cochrane Collaboration (<a href="./references#CD008415-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org. ">Higgins 2008</a>). The software package RevMan 5 provided by the Cochrane Collaboration was used (<a href="./references#CD008415-bbs2-0091" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008. ">RevMan 2008</a>). A random‐effects model (<a href="./references#CD008415-bbs2-0058" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>) and a fixed‐effect model were used (<a href="./references#CD008415-bbs2-0057" title="DeMetsDL . Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine1987;6(3):341‐50. ">DeMets 1987</a>). In the case of discrepancy between the two models, both results were reported; otherwise only the results from the fixed‐effect model were mentioned. HRs of overall survival and disease free survival obtained from the different trials were combined using the generic inverse variance method. </p> </section> <section id="CD008415-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The following subgroup analyses were planned.</p> <p> <ul id="CD008415-lst1-0013"> <li> <p>Trials with low risk of bias versus those with high risk of bias.</p> </li> <li> <p>Different types of chemotherapy as well as number of regimens and rate of cycles completed.</p> </li> <li> <p>Different surgical procedures (partial versus total gastrectomy).</p> </li> <li> <p>Different lymphadenectomy procedures (D1 versus D2 resection).</p> </li> <li> <p>Different approaches (open versus laparoscopic approach).</p> </li> <li> <p>Microscopically clear resection margin versus microscopically involved tumour margin.</p> </li> <li> <p>Different locations of tumour.</p> </li> <li> <p>Different histological types of gastric cancer.</p> </li> <li> <p>Different stages of gastric cancer (T1, T2 versus T3, T4).</p> </li> </ul> </p> <p>The Chi² test for subgroup differences was set at a P value of 0.05.</p> </section> <section id="CD008415-sec3-0017"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analysis was performed by excluding the trials which included gastric cancers at the gastro‐oesophageal junction. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008415-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008415-sec1-0005"></div> <section id="CD008415-sec2-0008"> <h3 class="title">Description of studies</h3> <section id="CD008415-sec3-0018"> <h4 class="title">Results of the search</h4> <p>A total of 3391 references were identified through the electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i>, MEDLINE, EMBASE, and Science Citation Index Expanded. The flow of references are shown in <a href="#CD008415-fig-0001">Figure 1</a>. A total of 467 duplicates and 2879 clearly irrelevant references were excluded through reading abstracts. Forty‐five references were retrieved for further assessment. Of the 45 references, 11 references were excluded because of the reasons listed in the table 'Characteristics of excluded studies'. Three references corresponded to the same study (<a href="./references#CD008415-bbs2-0035" title="AlcobendasF , MillaA , EstapeJ . Mitomycin C as an adjuvant in resected gastric cancer. Annals of Surgery1983;198(1):13‐7. ">Alcobendas 1983</a>; <a href="./references#CD008415-bbs2-0040" title="EstapeJ , GrauJJ , LcobendasF , CurtoJ , DanielsM , ViñolasN , et al. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10‐year follow‐up. Annals of Surgery1991;213(3):219‐21. ">Estape 1991</a>; <a href="./references#CD008415-bbs2-0015" title="GrauJJ , EstapéJ , AlcobendasF , PeraC , DanielsM , TerésJ . Positive results of adjuvant mitomycin‐C in resected gastric cancer: a randomised trial on 134 patients. European Journal of Cancer1993;29(3):340‐2. ">Grau 1993</a>) and hence the inclusion of two studies under the excluded studies. Of the remaining references, 34 randomised trials fulfilled the inclusion criteria. Once the full analysis of data was achieved the search strategy was rerun up to July 2013, in order to assure the presence of the most recent trials. This new search resulted in 189 new citations (MEDLINE= 129, EMBASE= 27, CENTRAL= 21, Science Citation Index= 68) of which only three were considered relevant. One of these remaining was excluded and listed in the table 'Characteristics of excluded studies' (<a href="./references#CD008415-bbs2-0038" title="ChenS , ChenYB , ZhouZW , LiW , SunXW , XuDZ , et alLi . No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer. American Journal of Clinical Oncology2011;34(3):309‐13. ">Chen 2011</a>) and the other two trials were added to the section “studies awaiting classification” (<a href="./references#CD008415-bbs2-0047" title="BangYJ , KimYW , YangHK , ChungHC , ParkYK , LeeKH , et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open‐label, randomised controlled trial. Lancet2012;379(9813):315‐21. ">Bang 2012</a>; <a href="./references#CD008415-bbs2-0048" title="SasakoM , SakuramotoS , KataiH , KinoshitaT , FurukawaH , YamaguchiT , et al. Five‐year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S‐1 versus surgery alone in stage II or III gastric cancer. Journal of Clinical Oncology2011;29(33):4387‐93. ">Sasako 2011</a>). </p> <div class="figure" id="CD008415-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD008415-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD008415-sec3-0019"> <h4 class="title">Included studies</h4> <p>All 34 trials were completed trials and could provide data for the analyses. Details of the trials are shown in the table '<a href="./references#CD008415-sec2-0029" title="">Characteristics of included studies</a>'. Overall the 34 trials included 7824 patients. The mean age of the individuals in the trials varied between 54 (<a href="./references#CD008415-bbs2-0019" title="KimJP , KwonOJ , OhST , YangHK . Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Annals of Surgery1992;216(3):269‐78. ">Kim 1992</a>) and 65 years (<a href="./references#CD008415-bbs2-0034" title="TentesAA , MarkakidisSK , KaranikiotisC , FiskaA , TentesIK , ManolopoulosVG , et al. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer. Langenbeck's Archives of Surgery2006;391(2):124–9. ">Tentes 2006</a>). The mean proportion of females varied between 19% (<a href="./references#CD008415-bbs2-0032" title="PopielaT , KuligJ , CzuprynaA , SzczepanikAM , ZembalaM . Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer2004;7:240–5. ">Popiela 2004</a>) to 47% (<a href="./references#CD008415-bbs2-0016" title="HallisseyMT , DunnJA , WardLC , AllumWH . The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five‐year follow‐up. Lancet1994;343(8909):1309‐12. ">Hallissey 1994</a>). There was no difference in the characteristics of patients in the intervention group and control group in any of the trials that reported these baseline characteristics. However, a wide variation was found between trials as the interventions were not exactly the same in all the studies. Differences were in terms of the drugs, doses and duration of the treatments as well as the design of the studies; but almost every trial based their intervention on 5‐fluorouracil (5‐FU) or platinum‐based chemotherapy (Platino), considered for separate analysis by subgroup. </p> </section> <section id="CD008415-sec3-0020"> <h4 class="title">Excluded studies</h4> <p>The reasons for exclusion of the studies are listed in the table '<a href="./references#CD008415-sec2-0030" title="">Characteristics of excluded studies</a>'. </p> </section> </section> <section id="CD008415-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias is summarised in the risk of bias graph (<a href="#CD008415-fig-0002">Figure 2</a>) and risk of bias summary (<a href="#CD008415-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD008415-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD008415-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD008415-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD008415-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD008415-sec3-0021"> <h4 class="title">Allocation</h4> <p>The generation of allocation sequence was adequate in six trials (<a href="./references#CD008415-bbs2-0002" title="BajettaE , BuzzoniR , MarianiL , BerettaE , BozzettiF , BordognaG , et al. Adjuvant chemotherapy in gastric cancer: 5‐year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology2002;13:299–307. ">Bajetta 2002</a>; <a href="./references#CD008415-bbs2-0005" title="ChipponiJ , HuguierM , PezetD , BassoN , HayJM , QuandalleP , et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. American Journal of Surgery2004;187(3):440–5. ">Chipponi 2004</a>; <a href="./references#CD008415-bbs2-0024" title="NakajimaT , NashimotoA , KitamuraM , KitoT , IwanagaT , OkabayashiK , et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plustegafur in serosa‐negative gastric cancer: a randomised trial. Lancet1999;354(9175):273–7. ">Nakajima 1999</a>; <a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a>; <a href="./references#CD008415-bbs2-0028" title="NittiD , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of Oncology2006;17(2):262–9. ">Nitti 2006 EORTC</a>; <a href="./references#CD008415-bbs2-0033" title="SakuramotoS , SasakoM , YamaguchiT , KinoshitaT , FujiiM , NashimotoA , et al. Adjuvant chemotherapy for gastric cancer with S‐1, an oral fluoropyrimidine. New England Journal of Medicine2007;357(18):1810‐20. ">Sakuramoto 2007</a>) and allocation concealment was adequate in 11 trials (<a href="./references#CD008415-bbs2-0003" title="BonfantiG . Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group. British Journal of Surgery1988;75(11):1100‐4. ">Bonfanti 1988</a>; <a href="./references#CD008415-bbs2-0007" title="CireraL , BalilA , Batiste‐AlentornE , TusquetsI , CardonaT , ArcusaA , et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. Journal of Clinical Oncology1999;17(12):3810‐5. ">Cirera 1999</a>; <a href="./references#CD008415-bbs2-0008" title="CoombesRC , ScheinPS , ChilversCE , WilsJ , BerettaG , BlissJM , et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Journal of Clinical Oncology1990;8(8):1362‐9. ">Coombes 1990</a>; <a href="./references#CD008415-bbs2-0016" title="HallisseyMT , DunnJA , WardLC , AllumWH . The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five‐year follow‐up. Lancet1994;343(8909):1309‐12. ">Hallissey 1994</a>; <a href="./references#CD008415-bbs2-0017" title="HigginsGA , AmadeoJH , SmithDE , HumphreyEW , KeehnRJ . Efficacy of prolonged intermittent therapy with combined 5‐FU and methyl‐CCNU following resection for gastric carcinoma. Cancer1983;52:1105‐12. ">Higgins 1983</a>; <a href="./references#CD008415-bbs2-0018" title="HuguierM , DestroyesJP , BaschetC , LeHenandF , BernardPF . Gastric carcinoma treated by chemotherapy after resection: a controlled study. American Journal of Surgery1980;139(2):197‐9. ">Huguier 1980</a>; <a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a>; <a href="./references#CD008415-bbs2-0026" title="NashimotoA , NakajimaT , FurukawaH , KitamuraM , KinoshitaT , YamamuraY , et al. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa‐negative gastric cancer: Japan Clinical Oncology Group 9206‐1. Journal of Clinical Oncology2003;21(12):2282‐7. ">Nashimoto 2003</a>; <a href="./references#CD008415-bbs2-0030" title="OchiaiT , SatoH , HayashiR , AsanoT , SatoH , YamamuraY . Postoperative adjuvant immunotherapy of gastric cancer with BCG‐cell wall skeleton. 3‐ to 6‐year follow up of a randomized clinical trial. Cancer Immunology, Immunotherapy1983;14(3):167‐71. ">Ochiai 1983</a>; <a href="./references#CD008415-bbs2-0032" title="PopielaT , KuligJ , CzuprynaA , SzczepanikAM , ZembalaM . Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer2004;7:240–5. ">Popiela 2004</a>; <a href="./references#CD008415-bbs2-0033" title="SakuramotoS , SasakoM , YamaguchiT , KinoshitaT , FujiiM , NashimotoA , et al. Adjuvant chemotherapy for gastric cancer with S‐1, an oral fluoropyrimidine. New England Journal of Medicine2007;357(18):1810‐20. ">Sakuramoto 2007</a>). </p> </section> <section id="CD008415-sec3-0022"> <h4 class="title">Blinding</h4> <p>Blinding was adequate in one trial (<a href="./references#CD008415-bbs2-0001" title="AllumWH , HallisseyMT , KellyKA . Adjuvant chemotherapy in operable gastric cancer. 5 year follow‐up of first British Stomach Cancer Group trial. LancetMarch, 1989;1(8638):571‐4. ">Allum 1989</a>) where the authors reported the use of placebo for the surgery alone arm in the same regimen as the chemotherapy was administrated to the intervention arm. </p> </section> <section id="CD008415-sec3-0023"> <h4 class="title">Incomplete outcome data</h4> <p>Five trials were free from bias due to incomplete outcome data (<a href="./references#CD008415-bbs2-0001" title="AllumWH , HallisseyMT , KellyKA . Adjuvant chemotherapy in operable gastric cancer. 5 year follow‐up of first British Stomach Cancer Group trial. LancetMarch, 1989;1(8638):571‐4. ">Allum 1989</a>; <a href="./references#CD008415-bbs2-0003" title="BonfantiG . Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group. British Journal of Surgery1988;75(11):1100‐4. ">Bonfanti 1988</a>; <a href="./references#CD008415-bbs2-0011" title="DouglasOH . Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group. Cancer1982;49(6):1116‐22. ">Douglas 1982</a>; <a href="./references#CD008415-bbs2-0012" title="EngstromPF , LawnPT , DouglasHO , BrunnerKW . Postoperative adjuvant 5‐fluorouracil plus methyl‐CCNU therapy for gastric cancer patients. Cancer1985;55(9):1868‐73. ">Engstrom 1985</a>; <a href="./references#CD008415-bbs2-0017" title="HigginsGA , AmadeoJH , SmithDE , HumphreyEW , KeehnRJ . Efficacy of prolonged intermittent therapy with combined 5‐FU and methyl‐CCNU following resection for gastric carcinoma. Cancer1983;52:1105‐12. ">Higgins 1983</a>). In 28 trials, there were post‐randomisation dropouts resulting in high risk of bias from incomplete outcome data. </p> </section> <section id="CD008415-sec3-0024"> <h4 class="title">Selective reporting</h4> <p>Twenty‐eight trials were free from bias due to selective reporting (<a href="./references#CD008415-bbs2-0001" title="AllumWH , HallisseyMT , KellyKA . Adjuvant chemotherapy in operable gastric cancer. 5 year follow‐up of first British Stomach Cancer Group trial. LancetMarch, 1989;1(8638):571‐4. ">Allum 1989</a>; <a href="./references#CD008415-bbs2-0002" title="BajettaE , BuzzoniR , MarianiL , BerettaE , BozzettiF , BordognaG , et al. Adjuvant chemotherapy in gastric cancer: 5‐year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology2002;13:299–307. ">Bajetta 2002</a>; <a href="./references#CD008415-bbs2-0004" title="BouchéO , YchouM , BurtinP , BedenneL , DucreuxM , LebretonG , et al. Adjuvant chemotherapy with 5‐fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7‐year results of the FFCD randomized phase III trial (8801). Annals of Oncology2005;16(9):1488–97. ">Bouché 2005</a>; <a href="./references#CD008415-bbs2-0005" title="ChipponiJ , HuguierM , PezetD , BassoN , HayJM , QuandalleP , et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. American Journal of Surgery2004;187(3):440–5. ">Chipponi 2004</a>; <a href="./references#CD008415-bbs2-0006" title="ChouFF , Sheen‐ChenSM , LiuPP , ChenFC . Adjuvant chemotherapy for resectable gastric cancer: a preliminary report. Journal of Surgical Oncology1994;57(4):239‐42. ">Chou 1994</a>; <a href="./references#CD008415-bbs2-0007" title="CireraL , BalilA , Batiste‐AlentornE , TusquetsI , CardonaT , ArcusaA , et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. Journal of Clinical Oncology1999;17(12):3810‐5. ">Cirera 1999</a>; <a href="./references#CD008415-bbs2-0008" title="CoombesRC , ScheinPS , ChilversCE , WilsJ , BerettaG , BlissJM , et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Journal of Clinical Oncology1990;8(8):1362‐9. ">Coombes 1990</a>; <a href="./references#CD008415-bbs2-0009" title="DeVitaF , GiulianiF , OrdituraM , MaielloE , GaliziaG , DiMartinoN , et al. Adjuvant chemotherapy with epirubicin, leucovorin,5‐fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase IIItrial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of Oncology2007;18(8):1354‐8. ">De Vitta 2007</a>; <a href="./references#CD008415-bbs2-0010" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of National Cancer Institute2008;100(6):388–98. ">Di Costanzo 2008</a>; <a href="./references#CD008415-bbs2-0011" title="DouglasOH . Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group. Cancer1982;49(6):1116‐22. ">Douglas 1982</a>; <a href="./references#CD008415-bbs2-0012" title="EngstromPF , LawnPT , DouglasHO , BrunnerKW . Postoperative adjuvant 5‐fluorouracil plus methyl‐CCNU therapy for gastric cancer patients. Cancer1985;55(9):1868‐73. ">Engstrom 1985</a>; <a href="./references#CD008415-bbs2-0013" title="FieldingJW , FaggSL , JonesBG , EllisD , HockeyMS , MinawaA , et al. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World Journal of Surgery1983;7(3):390‐9. ">Fielding 1983</a>; <a href="./references#CD008415-bbs2-0014" title="FujimotoS , AkaoT , ItohB , KoshizukaI , KoyanoK . Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Annals of Surgery1977;185(4):462‐6. ">Fujimoto 1977</a>; <a href="./references#CD008415-bbs2-0016" title="HallisseyMT , DunnJA , WardLC , AllumWH . The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five‐year follow‐up. Lancet1994;343(8909):1309‐12. ">Hallissey 1994</a>; <a href="./references#CD008415-bbs2-0017" title="HigginsGA , AmadeoJH , SmithDE , HumphreyEW , KeehnRJ . Efficacy of prolonged intermittent therapy with combined 5‐FU and methyl‐CCNU following resection for gastric carcinoma. Cancer1983;52:1105‐12. ">Higgins 1983</a>; <a href="./references#CD008415-bbs2-0018" title="HuguierM , DestroyesJP , BaschetC , LeHenandF , BernardPF . Gastric carcinoma treated by chemotherapy after resection: a controlled study. American Journal of Surgery1980;139(2):197‐9. ">Huguier 1980</a>; <a href="./references#CD008415-bbs2-0020" title="KrookJE , O'ConnellMJ , WieandHS , BeartRWJr , LeighJE , KuglerJW , et al. A prospective, randomized evaluation of intensive‐course 5‐fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer1991;67(10):2454‐8. ">Krook 1991</a>; <a href="./references#CD008415-bbs2-0022" title="LiseM , NittiD , MarchetA , SahmoudT , BuyseM , DuezN , et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. Journal of Clinical Oncology1995;13(11):2757‐63. ">Lise 1995</a>; <a href="./references#CD008415-bbs2-0023" title="MacdonaldJS , FlemingTR , PetersonRF , BerenbergJL , McClureS , ChapmanRA , et al. Adjuvant chemotherapy with 5‐FU, adriamycin, and mitomycin‐C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Annals of Surgical Oncology1995;2(6):488‐94. ">Macdonald 1995</a>; <a href="./references#CD008415-bbs2-0024" title="NakajimaT , NashimotoA , KitamuraM , KitoT , IwanagaT , OkabayashiK , et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plustegafur in serosa‐negative gastric cancer: a randomised trial. Lancet1999;354(9175):273–7. ">Nakajima 1999</a>; <a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a>; <a href="./references#CD008415-bbs2-0027" title="NeriB , CiniG , AndreoliF , BoffiB , FrancesconiD , MazzantiR , et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5‐year follow‐up. British Journal of Cancer2001;84(7):878–80. ">Neri 2001</a>; <a href="./references#CD008415-bbs2-0028" title="NittiD , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of Oncology2006;17(2):262–9. ">Nitti 2006 EORTC</a>; <a href="./references#CD008415-bbs2-0029" title="NittiJ , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCGD. Annals of Oncology2006;17:262–9. ">Nitti 2006 ICCG</a>; <a href="./references#CD008415-bbs2-0030" title="OchiaiT , SatoH , HayashiR , AsanoT , SatoH , YamamuraY . Postoperative adjuvant immunotherapy of gastric cancer with BCG‐cell wall skeleton. 3‐ to 6‐year follow up of a randomized clinical trial. Cancer Immunology, Immunotherapy1983;14(3):167‐71. ">Ochiai 1983</a>; <a href="./references#CD008415-bbs2-0031" title="PopielaT , ZembalaM , OszackiJ , JedrychowskiW . A follow‐up study on chemoimmunotherapy (5‐fluorouracil and BCG) in advanced gastric cancer. Cancer Immunology, Immunotherapy1982;13(3):182‐4. ">Popiela 1982</a>; <a href="./references#CD008415-bbs2-0032" title="PopielaT , KuligJ , CzuprynaA , SzczepanikAM , ZembalaM . Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer2004;7:240–5. ">Popiela 2004</a>; <a href="./references#CD008415-bbs2-0033" title="SakuramotoS , SasakoM , YamaguchiT , KinoshitaT , FujiiM , NashimotoA , et al. Adjuvant chemotherapy for gastric cancer with S‐1, an oral fluoropyrimidine. New England Journal of Medicine2007;357(18):1810‐20. ">Sakuramoto 2007</a>). </p> </section> <section id="CD008415-sec3-0025"> <h4 class="title">Other potential sources of bias</h4> <p>Fifteen trials were free from other potential sources of bias (<a href="./references#CD008415-bbs2-0001" title="AllumWH , HallisseyMT , KellyKA . Adjuvant chemotherapy in operable gastric cancer. 5 year follow‐up of first British Stomach Cancer Group trial. LancetMarch, 1989;1(8638):571‐4. ">Allum 1989</a>; <a href="./references#CD008415-bbs2-0002" title="BajettaE , BuzzoniR , MarianiL , BerettaE , BozzettiF , BordognaG , et al. Adjuvant chemotherapy in gastric cancer: 5‐year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology2002;13:299–307. ">Bajetta 2002</a>; <a href="./references#CD008415-bbs2-0003" title="BonfantiG . Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group. British Journal of Surgery1988;75(11):1100‐4. ">Bonfanti 1988</a>; <a href="./references#CD008415-bbs2-0004" title="BouchéO , YchouM , BurtinP , BedenneL , DucreuxM , LebretonG , et al. Adjuvant chemotherapy with 5‐fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7‐year results of the FFCD randomized phase III trial (8801). Annals of Oncology2005;16(9):1488–97. ">Bouché 2005</a>; <a href="./references#CD008415-bbs2-0007" title="CireraL , BalilA , Batiste‐AlentornE , TusquetsI , CardonaT , ArcusaA , et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. Journal of Clinical Oncology1999;17(12):3810‐5. ">Cirera 1999</a>; <a href="./references#CD008415-bbs2-0008" title="CoombesRC , ScheinPS , ChilversCE , WilsJ , BerettaG , BlissJM , et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Journal of Clinical Oncology1990;8(8):1362‐9. ">Coombes 1990</a>; <a href="./references#CD008415-bbs2-0010" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of National Cancer Institute2008;100(6):388–98. ">Di Costanzo 2008</a>; <a href="./references#CD008415-bbs2-0011" title="DouglasOH . Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group. Cancer1982;49(6):1116‐22. ">Douglas 1982</a>; <a href="./references#CD008415-bbs2-0012" title="EngstromPF , LawnPT , DouglasHO , BrunnerKW . Postoperative adjuvant 5‐fluorouracil plus methyl‐CCNU therapy for gastric cancer patients. Cancer1985;55(9):1868‐73. ">Engstrom 1985</a>; <a href="./references#CD008415-bbs2-0013" title="FieldingJW , FaggSL , JonesBG , EllisD , HockeyMS , MinawaA , et al. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World Journal of Surgery1983;7(3):390‐9. ">Fielding 1983</a>; <a href="./references#CD008415-bbs2-0014" title="FujimotoS , AkaoT , ItohB , KoshizukaI , KoyanoK . Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Annals of Surgery1977;185(4):462‐6. ">Fujimoto 1977</a>; <a href="./references#CD008415-bbs2-0016" title="HallisseyMT , DunnJA , WardLC , AllumWH . The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five‐year follow‐up. Lancet1994;343(8909):1309‐12. ">Hallissey 1994</a>; <a href="./references#CD008415-bbs2-0018" title="HuguierM , DestroyesJP , BaschetC , LeHenandF , BernardPF . Gastric carcinoma treated by chemotherapy after resection: a controlled study. American Journal of Surgery1980;139(2):197‐9. ">Huguier 1980</a>; <a href="./references#CD008415-bbs2-0023" title="MacdonaldJS , FlemingTR , PetersonRF , BerenbergJL , McClureS , ChapmanRA , et al. Adjuvant chemotherapy with 5‐FU, adriamycin, and mitomycin‐C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Annals of Surgical Oncology1995;2(6):488‐94. ">Macdonald 1995</a>; <a href="./references#CD008415-bbs2-0024" title="NakajimaT , NashimotoA , KitamuraM , KitoT , IwanagaT , OkabayashiK , et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plustegafur in serosa‐negative gastric cancer: a randomised trial. Lancet1999;354(9175):273–7. ">Nakajima 1999</a>). </p> </section> </section> <section id="CD008415-sec2-0010"> <h3 class="title" id="CD008415-sec2-0010">Effects of interventions</h3> <p>See: <a href="./full#CD008415-tbl-0001"><b>Summary of findings for the main comparison</b> Post‐surgical chemotherapy compared to surgery alone for resectable gastric cancer</a>; <a href="./full#CD008415-tbl-0002"><b>Summary of findings 2</b> Subgroup analysis for resectable gastric cancer</a>; <a href="./full#CD008415-tbl-0003"><b>Summary of findings 3</b> Subgroup analysis for resectable gastric cancer</a> </p> <section id="CD008415-sec3-0026"> <h4 class="title">Primary outcomes</h4> <section id="CD008415-sec4-0009"> <h5 class="title">Overall survival</h5> <p>A total of 34 trials (7523 participants) provided data on overall survival with homogeneous results (I² = 31%). Post‐surgical chemotherapy showed a significant beneficial effect on overall survival (HR 0.85; 95% CI 0.80 to 0.90) (<a href="#CD008415-fig-0004">Figure 4</a>; <a href="#CD008415-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD008415-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival." data-id="CD008415-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival. </p> </div> </div> </div> <div class="figure" id="CD008415-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival." data-id="CD008415-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival. </p> </div> </div> </div> </section> <section id="CD008415-sec4-0010"> <h5 class="title">Disease free survival</h5> <p>Of the 34 trials, 15 trials (4133 participants) also reported results regarding disease free survival, where post‐surgical chemotherapy showed a beneficial effect on disease free survival (HR 0.79; CI 0.72 to 0.87) (<a href="#CD008415-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD008415-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.2 Disesase free survival." data-id="CD008415-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.2 Disesase free survival. </p> </div> </div> </div> </section> </section> <section id="CD008415-sec3-0027"> <h4 class="title">Secondary outcomes</h4> <p>The planned analysis of quality of life, return to work, and number of hospital admissions was impossible to complete as the outcome data for the analysis were not available from any trials. </p> <section id="CD008415-sec4-0011"> <h5 class="title">Subgroup analysis</h5> <p>Planned subgroup analysis of different gastrectomy procedures, surgical approach, location of the tumour, microscopically affected margins, tumour location, and histological type were not performed as no outcome data for the different subgroups were available from the trials. </p> <p>Subgroup analysis based on the risk of bias in the trials was not performed as no trials were at low risk of bias, accepting as low risk of bias those where blinding, sequence generation and allocation concealment were properly applied and clearly reported. Despite the impossibility of achieving this analysis, allocation concealment was considered an important element and a subgroup analysis was performed according to this bias. Eleven trials with adequate allocation concealment were compared with 23 trials where allocation concealment was unclear or inadequate. The first subgroup showed an HR of 0.82 (95% CI 0.74 to 0.91) and the second subgroup showed an HR of 0.86 (95% CI 0.79 to 0.93) with no statistical difference when compared (P &gt; 0.05). </p> <p>For subgroup analysis by stage, only five trials provided data related to the tumour size (T1‐2 versus T3‐4). Analysis of the patients with T1‐2 tumour size revealed an HR of 0.86 (95% CI 0.71 to 1.05) while those with T3‐4 tumours showed an HR of 0.66 (95% CI 0.41 to 1.08). However, no significant difference was shown when compared (Chi² = 0.93, df = 1, P = 0.34; I² = 0%). </p> <p>For subgroup analysis by lymph node involvement, four included studies described independent analyses related to lymph node status (N). For N ‐ (absence of lymph node metastasis) the HR was 0.74 (95% CI 0.41 to 1.33) and for N + (lymph node metastasis) the HR was 0.78 (95% CI 0.67 to 0.91). Again, no differences were shown between groups (Chi² = 0.03, df = 1, P = 0.86; I² = 0%). </p> <p>In the subgroup analysis by chemotherapy agent, from all studies 29 trials based the post‐surgical chemotherapy on the use of 5‐FU, alone or combined with other drugs. The analysis revealed an overall survival benefit with an HR of 0.88 (95% CI 0.83 to 0.94); while those trials where platinum‐based chemotherapy was used (eight included trials) the HR for overall survival was 0.90 (95% CI 0.81 to 1.00). The analysis of disease free survival for both groups showed similar results. Fourteen 5‐FU based trials reported data on disease free survival and showed an HR of 0.86 (95% CI 0.78 to 0.95). Only four platinum‐based studies reported data on disease free survival where the HR was 0.89 (95% CI 0.75 to 1.06). Nevertheless, overall survival and disease free survival did not show statistically significant differences between groups when compared. Test for subgroup differences for overall survival: Chi² = 0.16, df = 1, P = 0.69; I² = 0%; and for disease free survival: Chi² = 0.15, df = 1, P = 0.70; I² = 0%. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008415-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008415-sec1-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008415-sec1-0021">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008415-sec1-0006"></div> <p>Gastric cancer is one of the most important neoplasms of the digestive tract due to its high incidence and mortality. Over 21,000 new cases were expected in USA in 2010 as well as more than 10,000 expected deaths for both sexes (<a href="./references#CD008415-bbs2-0075" title="JemalA , SiegelR , XuJ , WardE . Cancer statistics 2010. CA: A Cancer Journal for Clinicians2010;60(5):277‐300. ">Jemal 2010</a>). Such a rate is caused by the fact that despite the advances achieved in the management of this pathology, overall survival rates including all stages do not exceed 20% (<a href="./references#CD008415-bbs2-0052" title="CrewKD , NeugutAI . Epidemiology of gastric cancer. World Journal of Gastroenterology2006;12(3):354‐62. [PUBMED: 16489633] ">Crew 2006</a>). A particular consideration of gastric cancer is the historical difference between oriental and occidental series. Countries like Japan and China have described a higher incidence of this pathology and their screening programs have reached historically higher early stage diagnosis rates. Also, the reported overall survival and disease free survival rates were commonly better than those reported in occidental trials. </p> <section id="CD008415-sec2-0011"> <h3 class="title" id="CD008415-sec2-0011">Surgery</h3> <p>Irrespective of the series origin, treatment of this malignancy is based on surgical resection, which represents the only curative option today. Complete tumour resection is currently the target of treatment, and provides the basis on which the therapeutic strategy is supported. </p> <p>The described interventions are partial or total gastrectomy and, in relation to the technique, available data do not allow us to assess differences between the procedures regarding survival. Main series of patients where total gastrectomy is compared with subtotal gastrectomy do not indicate any improvement in terms of survival (<a href="./references#CD008415-bbs2-0093" title="ShiY , ZhouY . The role of surgery in the treatment of gastric cancer. Journal of Surgical Oncology2010;101:687‐92. ">Shi 2010</a>). Factors determining survival are margin invasion and lymph node status (<a href="./references#CD008415-bbs2-0068" title="GouziJL , HuguierM , FaqniezPL , LaunoisB , FlamantY , LacaineF , et al. Total gastrectomy versus partial gastrectomy of adenocarcinoma of the antrum. A French prospective controlled study. Annales de Chirugie1989;43(5):356‐60. ">Gouzi 1989</a>; <a href="./references#CD008415-bbs2-0093" title="ShiY , ZhouY . The role of surgery in the treatment of gastric cancer. Journal of Surgical Oncology2010;101:687‐92. ">Shi 2010</a>). In addition, for total gastrectomy the postoperative quality of life is significantly worse when compared with quality of life after subtotal gastrectomy (<a href="./references#CD008415-bbs2-0055" title="DaviesJ , JohnstonD , Sue‐LingH , YoungS , MayJ , GriffithJ , et al. Total or subtotal gastrectomy for gastric adenocarcinoma? A study of quality of life. World Journal of Surgery1998;22(10):1048‐55. ">Davies 1998</a>). In the present review, the surgical procedure was only mentioned as part of the initial description of baseline characteristics of patients in the trials and no further comparison was reported related to it. </p> </section> <section id="CD008415-sec2-0012"> <h3 class="title" id="CD008415-sec2-0012">Lymphadenectomy</h3> <p>Every surgical resection commonly includes some degree of lymphadenectomy. Gastric cancer may be one of the neoplasms, similar to breast cancer, where lymphadenectomy procedures are very well described and also have standardised grades. Worldwide, four grades of lymphadenectomy are accepted for gastric cancer and they are meticulously described, in ascending order of extent, as D1, D2, D3 and D4. </p> <p>Differences between oriental and occidental series arise again in relation to this topic. D2 was initially described as a safe procedure that produced incremental overall survival and disease free survival rates in oriental series (<a href="./references#CD008415-bbs2-0085" title="NakajimaT . Gastric cancer treatment guidelines in Japan. Gastric Cancer2002;5(1):1‐5. ">Nakajima 2002</a>); while prospective European trials like the Dutch Gastric Cancer Trial (DGCT) and UK Medical Research Council (MRC) did not show any survival benefit for D2 lymphadenectomy, and described a significantly higher morbidity rate associated with this procedure (<a href="./references#CD008415-bbs2-0054" title="CuschieriA , WeedenS , FieldingJ , BancewiczJ , CravenJ , JoypaulV , et al. Patient survival after D1 and D2 resections for gastric cancer: long‐term results of the MRC randomized surgical trial. Surgical Co‐operative group. British Journal of Cancer1999;79(9‐10):1522‐30. ">Cuschieri 1999</a>; <a href="./references#CD008415-bbs2-0070" title="HartgrinkHH , van deVeldeCJ , PutterH , BonenkampJJ , Klein KranenbargE , SongunI , et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. Journal of Clinical Oncology2004;22(11):2069‐77. ">Hartgrink 2004</a>). Recently, similar studies have reported that pancreas resection seems to be the main cause of morbidity related to lymphadenectomy, hence pancreas preserving D2 lymphadenectomy may have a survival benefit without an incremental increase in morbidity (<a href="./references#CD008415-bbs2-0056" title="DegiuliM , SasakoM , CalgaroM , GarinoM , RebecchiF , MinecciaM , et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. European Journal of Surgical Oncology2004;30(3):303‐8. ">Degiuli 2004</a>; <a href="./references#CD008415-bbs2-0102" title="WuCW , HsiungCA , LoSS , HsiehMC , ChenJH , LiAF , et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncology2006;7(4):309‐15. ">Wu 2006</a>). The standardisation and implementation of this type of surgery appears to be, at present, the main recommendation (<a href="./references#CD008415-bbs2-0095" title="SongunI , PutterH , KranenbargEM , SasakoM , Van deVeldeCJ . Surgical treatment of gastric cancer: 15‐year follow‐up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncology2010;11(5):439‐49. ">Songun 2010</a>). </p> </section> <section id="CD008415-sec2-0013"> <h3 class="title" id="CD008415-sec2-0013">Chemotherapy</h3> <p>Once an adequate surgical procedure and D2 lymphadenectomy have been performed, post‐surgical chemotherapy would be the next step in the management of gastric cancer. Results reported in this meta‐analysis conclude that chemotherapy should be the general recommendation, with an overall survival benefit of 15% (HR 0.85) and disease free survival benefit of 21% (HR 0.79), however no standard regimen is available due to the contradictory results. Platinum‐based regimens of chemotherapy have clearly failed to show survival benefit in recent trials (<a href="./references#CD008415-bbs2-0002" title="BajettaE , BuzzoniR , MarianiL , BerettaE , BozzettiF , BordognaG , et al. Adjuvant chemotherapy in gastric cancer: 5‐year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology2002;13:299–307. ">Bajetta 2002</a>; <a href="./references#CD008415-bbs2-0021" title="KuligJ , KolodziejczykP , SierzegaM , BobrzynskiL , JedrysJ , PopielaT , et al. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology2010;78(1):54‐61. ">Kulig 2010</a>) and our subgroup analysis also support these results. Considering the estimated HRs for overall survival (OS) and disease free survival (DFS) in the platinum‐based chemotherapy group (HR 0.90; 95% CI 0.81 to 1.00 and HR 0.89; 95% CI 0.75 to 1.06, respectively) no survival benefit can be assumed with the use of these regimens. The estimated HR for the 5‐FU based chemotherapy group does reveal a survival benefit (HR 0.88 for OS and HR 0.86 for DFS; P &lt; 0.05 in both cases); despite no statistically significant difference when both groups were compared (P &gt; 0.05). These findings are consistent with regard to recent recommendations and current guidelines (<a href="./references#CD008415-bbs2-0088" title="OkinesA , VerheijM , AllumW , CunninghamD , CervantesA , ESMO Guidelines Working Group. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Annals of Oncology2010;21(5):50‐4. ">Okines 2010</a>). </p> <p>As a result, new therapeutical regimens are being developed and the combination of perioperative chemotherapy (pre and post‐surgical chemotherapy) with radiotherapy is accepted in current treatment protocols based on two studies that reported survival benefit (<a href="./references#CD008415-bbs2-0039" title="CunninghamD , AllumWH , StenningSP , ThompsonJN , Van deVeldeCJ , NicolsonM , et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine2006;355(1):11‐20. ">Cunninghan 2006</a>; <a href="./references#CD008415-bbs2-0041" title="MacdonaldJS , SmalleySR , BenedettiJ , HundahlSA , EstesNC , StemmermannGN , et al. Chemotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New England Journal of Medicine2001;345(10):725‐30. ">Macdonald 2001</a>), both based on a fluouracil‐type agent regime. </p> </section> <section id="CD008415-sec2-0014"> <h3 class="title" id="CD008415-sec2-0014">Toxicity</h3> <p>Chemotherapy administration has important related morbidity. The US Food and Drug Administration (<a href="./references#CD008415-bbs2-0064" title="Food , DrugsAdministration . US Food and Drug Administration home page. www.fda.gov (accessed 17 January 2012). ">FDA</a>) reports an adverse effect rate close to 100% for the use of 5‐FU (<a href="./references#CD008415-bbs2-0064" title="Food , DrugsAdministration . US Food and Drug Administration home page. www.fda.gov (accessed 17 January 2012). ">FDA</a>), including grades 1 to 4 of the WHO adverse effects classification, and this is confirmed in some trials that report a toxicity rate of 94% when considering grades 1 and 2 (<a href="./references#CD008415-bbs2-0023" title="MacdonaldJS , FlemingTR , PetersonRF , BerenbergJL , McClureS , ChapmanRA , et al. Adjuvant chemotherapy with 5‐FU, adriamycin, and mitomycin‐C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Annals of Surgical Oncology1995;2(6):488‐94. ">Macdonald 1995</a>). Commonly these initial toxicity grades are not included in studies and this rate varies from 15% to 55% (<a href="./references#CD008415-bbs2-0004" title="BouchéO , YchouM , BurtinP , BedenneL , DucreuxM , LebretonG , et al. Adjuvant chemotherapy with 5‐fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7‐year results of the FFCD randomized phase III trial (8801). Annals of Oncology2005;16(9):1488–97. ">Bouché 2005</a>; <a href="./references#CD008415-bbs2-0010" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of National Cancer Institute2008;100(6):388–98. ">Di Costanzo 2008</a>; <a href="./references#CD008415-bbs2-0021" title="KuligJ , KolodziejczykP , SierzegaM , BobrzynskiL , JedrysJ , PopielaT , et al. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology2010;78(1):54‐61. ">Kulig 2010</a>; <a href="./references#CD008415-bbs2-0034" title="TentesAA , MarkakidisSK , KaranikiotisC , FiskaA , TentesIK , ManolopoulosVG , et al. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer. Langenbeck's Archives of Surgery2006;391(2):124–9. ">Tentes 2006</a>). Special mention is required concerning the current use of S‐1 (contains tegafur, a substance that converts to 5‐FU in the body) therapy, with reports of an adverse effect rate of 6% (<a href="./references#CD008415-bbs2-0033" title="SakuramotoS , SasakoM , YamaguchiT , KinoshitaT , FujiiM , NashimotoA , et al. Adjuvant chemotherapy for gastric cancer with S‐1, an oral fluoropyrimidine. New England Journal of Medicine2007;357(18):1810‐20. ">Sakuramoto 2007</a>). </p> <p>Adverse effects related to chemotherapy do not represent an outcome that can be used to compare groups as they are only relevant to one arm of the trials, however they have a huge impact on patients receiving these kind of treatments. Our data reveal that only 21 of the included studies reported data related to adverse effects (<a href="#CD008415-tbl-0006">Table 1</a>). Nausea and vomiting is the most common toxicity related to chemotherapy, considering our data, with 565 events in 2345 patients (24% incidence) followed by leukopenia with 500 events in 2506 patients (20% incidence). </p> <div class="table" id="CD008415-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse effects</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Anaemia events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Leukopenia events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Thrombopenia events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nausea/Vomiting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0002" title="BajettaE , BuzzoniR , MarianiL , BerettaE , BozzettiF , BordognaG , et al. Adjuvant chemotherapy in gastric cancer: 5‐year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology2002;13:299–307. ">Bajetta 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 135</p> <p>Cont.: 136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0004" title="BouchéO , YchouM , BurtinP , BedenneL , DucreuxM , LebretonG , et al. Adjuvant chemotherapy with 5‐fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7‐year results of the FFCD randomized phase III trial (8801). Annals of Oncology2005;16(9):1488–97. ">Bouché 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 127</p> <p>Cont.: 133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0005" title="ChipponiJ , HuguierM , PezetD , BassoN , HayJM , QuandalleP , et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. American Journal of Surgery2004;187(3):440–5. ">Chipponi 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 93</p> <p>Cont.: 103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0008" title="CoombesRC , ScheinPS , ChilversCE , WilsJ , BerettaG , BlissJM , et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Journal of Clinical Oncology1990;8(8):1362‐9. ">Coombes 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 133</p> <p>Cont.: 148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0009" title="DeVitaF , GiulianiF , OrdituraM , MaielloE , GaliziaG , DiMartinoN , et al. Adjuvant chemotherapy with epirubicin, leucovorin,5‐fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase IIItrial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of Oncology2007;18(8):1354‐8. ">De Vitta 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 112</p> <p>Cont.: 113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0010" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of National Cancer Institute2008;100(6):388–98. ">Di Costanzo 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 130</p> <p>Cont.: 128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0013" title="FieldingJW , FaggSL , JonesBG , EllisD , HockeyMS , MinawaA , et al. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World Journal of Surgery1983;7(3):390‐9. ">Fielding 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 141</p> <p>Cont.: 130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113</p> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93</p> <p>73</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0014" title="FujimotoS , AkaoT , ItohB , KoshizukaI , KoyanoK . Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Annals of Surgery1977;185(4):462‐6. ">Fujimoto 1977</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 97</p> <p>Cont.: 120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0015" title="GrauJJ , EstapéJ , AlcobendasF , PeraC , DanielsM , TerésJ . Positive results of adjuvant mitomycin‐C in resected gastric cancer: a randomised trial on 134 patients. European Journal of Cancer1993;29(3):340‐2. ">Grau 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 68</p> <p>Cont.: 66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0017" title="HigginsGA , AmadeoJH , SmithDE , HumphreyEW , KeehnRJ . Efficacy of prolonged intermittent therapy with combined 5‐FU and methyl‐CCNU following resection for gastric carcinoma. Cancer1983;52:1105‐12. ">Higgins 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 66</p> <p>Cont.: 68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0020" title="KrookJE , O'ConnellMJ , WieandHS , BeartRWJr , LeighJE , KuglerJW , et al. A prospective, randomized evaluation of intensive‐course 5‐fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer1991;67(10):2454‐8. ">Krook 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 61</p> <p>Cont.: 64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0022" title="LiseM , NittiD , MarchetA , SahmoudT , BuyseM , DuezN , et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. Journal of Clinical Oncology1995;13(11):2757‐63. ">Lise 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 155</p> <p>Cont.: 159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0023" title="MacdonaldJS , FlemingTR , PetersonRF , BerenbergJL , McClureS , ChapmanRA , et al. Adjuvant chemotherapy with 5‐FU, adriamycin, and mitomycin‐C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Annals of Surgical Oncology1995;2(6):488‐94. ">Macdonald 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 93</p> <p>Cont.: 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0024" title="NakajimaT , NashimotoA , KitamuraM , KitoT , IwanagaT , OkabayashiK , et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plustegafur in serosa‐negative gastric cancer: a randomised trial. Lancet1999;354(9175):273–7. ">Nakajima 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 288</p> <p>Cont.: 285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 93</p> <p>Cont.: 95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0026" title="NashimotoA , NakajimaT , FurukawaH , KitamuraM , KinoshitaT , YamamuraY , et al. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa‐negative gastric cancer: Japan Clinical Oncology Group 9206‐1. Journal of Clinical Oncology2003;21(12):2282‐7. ">Nashimoto 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 127</p> <p>Cont.: 123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0027" title="NeriB , CiniG , AndreoliF , BoffiB , FrancesconiD , MazzantiR , et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5‐year follow‐up. British Journal of Cancer2001;84(7):878–80. ">Neri 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 69</p> <p>Cont.: 68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0028" title="NittiD , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of Oncology2006;17(2):262–9. ">Nitti 2006 EORTC</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 103</p> <p>Cont.: 103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0029" title="NittiJ , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCGD. Annals of Oncology2006;17:262–9. ">Nitti 2006 ICCG</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 91</p> <p>Cont.: 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0032" title="PopielaT , KuligJ , CzuprynaA , SzczepanikAM , ZembalaM . Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer2004;7:240–5. ">Popiela 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 53</p> <p>Cont.: 52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0033" title="SakuramotoS , SasakoM , YamaguchiT , KinoshitaT , FujiiM , NashimotoA , et al. Adjuvant chemotherapy for gastric cancer with S‐1, an oral fluoropyrimidine. New England Journal of Medicine2007;357(18):1810‐20. ">Sakuramoto 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 517</p> <p>Cont.: 526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> <p>16</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Interv.: Intervention group (postsurgical chemotherapy).</p> <p>Cont.: Control group (surgery alone).</p> <p>NR: not reported.</p> </div> </div> </section> <section id="CD008415-sec2-0015"> <h3 class="title" id="CD008415-sec2-0015">Staging</h3> <p>Stage‐related treatment is the most controversial topic. Results of our review show general OS and DFS benefit including all stages, nevertheless the prognosis is different in every stage and the beneficial effect may be related to the more important benefit on higher grading. Subgroup analysis was completed by tumour size but few articles reported their data and no differences between groups were found (P &gt; 0.05). Despite no statistical significance a greater beneficial effect was shown in the T3‐4 group (HR 0.66 versus HR 0.86 for T1‐2 group). Against this, <a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a> described survival benefit with the use of post‐surgical chemotherapy for patients with serosa‐negative gastric cancer, but all included patients also had lymph node metastasis. </p> <p>Regarding post‐surgical chemotherapy administration and N status, some studies affirm that lymph node metastases (N +) represents an independent poor prognosis factor (<a href="./references#CD008415-bbs2-0004" title="BouchéO , YchouM , BurtinP , BedenneL , DucreuxM , LebretonG , et al. Adjuvant chemotherapy with 5‐fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7‐year results of the FFCD randomized phase III trial (8801). Annals of Oncology2005;16(9):1488–97. ">Bouché 2005</a>; <a href="./references#CD008415-bbs2-0032" title="PopielaT , KuligJ , CzuprynaA , SzczepanikAM , ZembalaM . Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer2004;7:240–5. ">Popiela 2004</a>), however few studies reported separate analyses. Subgroup analysis again shows a more important survival benefit for the N + group (HR 0.78; 95% CI 0.67 to 0.91 versus HR 0.74; 95% CI 0.41 to 1.33 for N ‐) despite the fact that there was no statistical significance when both groups were compared (P &gt; 0.05). It seems easy to assume that post‐surgical chemotherapy should be considered as part of the treatment of gastric cancer with lymph node involvement in relation to trials that failed to demonstrate general survival benefit including all the stages but that report survival benefit for the N + group (<a href="./references#CD008415-bbs2-0009" title="DeVitaF , GiulianiF , OrdituraM , MaielloE , GaliziaG , DiMartinoN , et al. Adjuvant chemotherapy with epirubicin, leucovorin,5‐fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase IIItrial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of Oncology2007;18(8):1354‐8. ">De Vitta 2007</a>). However, doubts arise in the situation where D2 lymphadenectomy has been performed correctly and there is no evidence of lymph node metastasis. We understand that potential survival improvement with chemotherapy remains unclear in these stages. In summary, from the current analysis we agree that patients without nodal or serosa involvement are unlike to benefit from post‐surgical chemotherapy (<a href="./references#CD008415-bbs2-0026" title="NashimotoA , NakajimaT , FurukawaH , KitamuraM , KinoshitaT , YamamuraY , et al. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa‐negative gastric cancer: Japan Clinical Oncology Group 9206‐1. Journal of Clinical Oncology2003;21(12):2282‐7. ">Nashimoto 2003</a>). </p> </section> <section id="CD008415-sec2-0016"> <h3 class="title" id="CD008415-sec2-0016">Quality of life</h3> <p>Quality of life is not described in any of the included studies, but it represents a fundamental fact in oncological patients. The closest related reference is the study of Al‐Batran (<a href="./references#CD008415-bbs2-0049" title="Al‐BatranSE , AjaniJA . Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer. Cancer2010;116(11):2511‐8. ">Al‐Batran 2010</a>) where they analysed the quality of life related to chemotherapy of patients with metastatic oesophagogastric cancer. Generally, studies that are available do not describe any improvements in the quality of life due to the administration of chemotherapy. Only fluorouracil‐based and platinum‐based regimens seem to improve, in some measure, the quality of life or at least they preserve it. Direct effects of adjuvant treatment on quality of life in those patients operated on with curative intention should be evaluated in the future and properly designed trials with low risk of bias should include quality of life as a main outcome. </p> </section> <section id="CD008415-sec2-0017"> <h3 class="title" id="CD008415-sec2-0017">Cost‐effectiveness</h3> <p>None of the included or excluded studies mentioned the cost‐effectiveness of implementation of post‐surgical chemotherapy. Recent trials that evaluate the cost‐effectiveness of new drugs in advanced gastric cancer have concluded that these therapies might not be cost‐effective (<a href="./references#CD008415-bbs2-0103" title="WuB , YeM , ChenH , ShenJF . Costs of trastuzumab in combination with chemotherapy for HER2‐positive advanced gastric or gastroesophageal junction cancer: an economic evaluation in the Chinese context. Clinical Therapeutics2012;34(2):468‐79. ">Wu 2012</a>). In this sense, well‐developed trials should investigate the cost‐effectiveness of post‐surgical chemotherapy. </p> </section> <section id="CD008415-sec2-0018"> <h3 class="title" id="CD008415-sec2-0018">Summary of main results</h3> <section id="CD008415-sec3-0028"> <h4 class="title">Post‐surgical chemotherapy</h4> <p>Post‐surgical chemotherapy shows a survival benefit for patients with gastric cancer, for OS (HR 0.85; 95% CI 0.80 to 0.90) and for DFS (HR 0.79; 95% CI 0.72 to 0.87). </p> </section> <section id="CD008415-sec3-0029"> <h4 class="title">Subgroup analysis</h4> <p>Post‐surgical chemotherapy shows overall survival benefit for patients with gastric cancer and N + status (HR 0.78; 95% CI 0.67 to 0.91) despite the fact no significant differences were found when compared with the N ‐ group (P &gt; 0.05). </p> </section> </section> <section id="CD008415-sec2-0019"> <h3 class="title" id="CD008415-sec2-0019">Overall completeness and applicability of evidence</h3> <p>This review included patients undergoing gastric surgery for resectable gastric adenocarcinoma, including total or partial gastrectomies, irrespective of the lymphadenectomy procedure. Hence this review is applicable to most patients with resectable gastric cancer. </p> </section> <section id="CD008415-sec2-0020"> <h3 class="title" id="CD008415-sec2-0020">Quality of the evidence</h3> <p>Most of the trials were at high risk of bias. Allocation was unclear in most of the trials. Blinding was not performed in most of the trials. Some of the trials did not report all the prespecified outcomes. </p> </section> <section id="CD008415-sec2-0021"> <h3 class="title" id="CD008415-sec2-0021">Potential biases in the review process</h3> <p>The <i>Cochrane Handbook for Systematic Reviews of Interventions</i> was followed for this review. There were no language, publication status, or sample size restrictions. Thus, bias due to selection of trials was minimized. There was no reporting bias as suggested by the funnel plot and Egger's linear regression approach (<a href="./references#CD008415-bbs2-0062" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. ">Egger 1997</a>). </p> <p>Per protocol analysis was used when intention‐to‐treat analysis or available case analysis was not possible. This could lead to bias favouring the intervention. </p> </section> <section id="CD008415-sec2-0022"> <h3 class="title" id="CD008415-sec2-0022">Agreements and disagreements with other studies or reviews</h3> <p>Old reviews regarding the use of post‐surgical chemotherapy failed to demonstrate any survival benefit (<a href="./references#CD008415-bbs2-0071" title="HermansJ , BonenkampJJ , BoonMC , BuntAM , OhyamaS , SasakoM , Van deVeldeCJ . Adjuvant therapy after curative resection for gastric cancer: meta‐analysis of randomized trials. Journal of Clinical Oncology1993;11(8):1441‐7. ">Hermans 1993</a>). More recent reviews show higher rates of overall survival with statistical significance in patients treated with chemotherapy after surgical resection (<a href="./references#CD008415-bbs2-0089" title="PaolettiX , ObaK , BurzykowskiT , MichielsS , OhashiY , PignonJP , et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta‐analysis. JAMA2010;303(17):1729‐37. ">Paoletti 2010</a>; <a href="./references#CD008415-bbs2-0097" title="SunP , XiangJB , ChenZY . Meta‐analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. British Journal of Surgery2009;96(1):26‐33. ">Sun 2009</a>). Results of this review are similar to those more recent publications and they support that there is not a standard regimen of chemotherapy accepted. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008415-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD008415-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD008415-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD008415-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival." data-id="CD008415-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival." data-id="CD008415-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.1 Overal survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.2 Disesase free survival." data-id="CD008415-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Post‐surgical chemotherapy versus surgery alone, outcome: 1.2 Disesase free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Post‐surgical chemotherapy versus surgery alone, Outcome 1 Overal Survival." data-id="CD008415-fig-00101" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Post‐surgical chemotherapy versus surgery alone, Outcome 1 Overal Survival.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Post‐surgical chemotherapy versus surgery alone, Outcome 2 Disesase free survival." data-id="CD008415-fig-00102" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Post‐surgical chemotherapy versus surgery alone, Outcome 2 Disesase free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis, Outcome 1 Chemobased OS." data-id="CD008415-fig-00201" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis, Outcome 1 Chemobased OS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis, Outcome 2 Stage OS analysis." data-id="CD008415-fig-00202" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis, Outcome 2 Stage OS analysis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis, Outcome 3 Lymph node mets analysis." data-id="CD008415-fig-00203" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis, Outcome 3 Lymph node mets analysis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis, Outcome 4 Chemobased DFS." data-id="CD008415-fig-00204" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis, Outcome 4 Chemobased DFS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008415-fig-00205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/urn:x-wiley:14651858:media:CD008415:CD008415-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_t/tCD008415-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis, Outcome 5 Low Risk of Bias." data-id="CD008415-fig-00205" src="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis, Outcome 5 Low Risk of Bias.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-fig-00205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/media/CDSR/CD008415/image_n/nCD008415-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008415-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Post‐surgical chemotherapy compared to surgery alone for resectable gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Post‐surgical chemotherapy compared to surgery alone for resectable gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with resectable gastric cancer<br/> <b>Settings:</b> <br/> <b>Intervention:</b> Post‐surgical chemotherapy<br/> <b>Comparison:</b> Surgery alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall Survival (OS)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.85</b> <br/> (0.80 to 0.90) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7523<br/> (34 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Disease Free Survival</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.79</b> <br/> (0.72 to 0.87) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4133<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> Very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Post‐surgical chemotherapy compared to surgery alone for resectable gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008415-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subgroup analysis for resectable gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Subgroup analysis for resectable gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with resectable gastric cancer<br/> <b>Settings:</b> <br/> <b>Intervention:</b> Subgroup analysis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased OS ‐ 5‐FU based chemotherapy OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.88</b> <br/> (0.83 to 0.94) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5694<br/> (28 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased OS ‐ Platinum‐based chemotherapy OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.9</b> <br/> (0.81 to 1) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1504<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased DFS ‐ 5‐FU based chemotherapy DFS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.86</b> <br/> (0.78 to 0.95) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2944<br/> (13 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Chemobased DFS ‐ Platinum‐based chemotherapy DFS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.89</b> <br/> (0.75 to 1.06) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>969<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> Very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subgroup analysis for resectable gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008415-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Subgroup analysis for resectable gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Subgroup analysis for resectable gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with resectable gastric cancer<br/> <b>Settings:</b> <br/> <b>Intervention:</b> Subgroup analysis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stage OS analysis ‐ T1/2 OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.86</b> <br/> (0.71 to 1.05) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1146<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stage OS analysis ‐ T3/4 OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.66</b> <br/> (0.41 to 1.08) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1008<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lymph node mets analysis ‐ N‐ OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.74</b> <br/> (0.41 to 1.33) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>402<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lymph node mets analysis ‐ N+ OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.78</b> <br/> (0.67 to 0.91) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>877<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> Very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Subgroup analysis for resectable gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008415-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse effects</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Anaemia events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Leukopenia events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Thrombopenia events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nausea/Vomiting</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0002" title="BajettaE , BuzzoniR , MarianiL , BerettaE , BozzettiF , BordognaG , et al. Adjuvant chemotherapy in gastric cancer: 5‐year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology2002;13:299–307. ">Bajetta 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 135</p> <p>Cont.: 136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0004" title="BouchéO , YchouM , BurtinP , BedenneL , DucreuxM , LebretonG , et al. Adjuvant chemotherapy with 5‐fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7‐year results of the FFCD randomized phase III trial (8801). Annals of Oncology2005;16(9):1488–97. ">Bouché 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 127</p> <p>Cont.: 133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0005" title="ChipponiJ , HuguierM , PezetD , BassoN , HayJM , QuandalleP , et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. American Journal of Surgery2004;187(3):440–5. ">Chipponi 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 93</p> <p>Cont.: 103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0008" title="CoombesRC , ScheinPS , ChilversCE , WilsJ , BerettaG , BlissJM , et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Journal of Clinical Oncology1990;8(8):1362‐9. ">Coombes 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 133</p> <p>Cont.: 148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0009" title="DeVitaF , GiulianiF , OrdituraM , MaielloE , GaliziaG , DiMartinoN , et al. Adjuvant chemotherapy with epirubicin, leucovorin,5‐fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase IIItrial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of Oncology2007;18(8):1354‐8. ">De Vitta 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 112</p> <p>Cont.: 113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0010" title="DiCostanzoF , GasperoniS , ManzioneL , BisagniG , LabiancaR , BraviS , et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Journal of National Cancer Institute2008;100(6):388–98. ">Di Costanzo 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 130</p> <p>Cont.: 128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0013" title="FieldingJW , FaggSL , JonesBG , EllisD , HockeyMS , MinawaA , et al. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World Journal of Surgery1983;7(3):390‐9. ">Fielding 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 141</p> <p>Cont.: 130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113</p> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93</p> <p>73</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0014" title="FujimotoS , AkaoT , ItohB , KoshizukaI , KoyanoK . Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Annals of Surgery1977;185(4):462‐6. ">Fujimoto 1977</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 97</p> <p>Cont.: 120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0015" title="GrauJJ , EstapéJ , AlcobendasF , PeraC , DanielsM , TerésJ . Positive results of adjuvant mitomycin‐C in resected gastric cancer: a randomised trial on 134 patients. European Journal of Cancer1993;29(3):340‐2. ">Grau 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 68</p> <p>Cont.: 66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0017" title="HigginsGA , AmadeoJH , SmithDE , HumphreyEW , KeehnRJ . Efficacy of prolonged intermittent therapy with combined 5‐FU and methyl‐CCNU following resection for gastric carcinoma. Cancer1983;52:1105‐12. ">Higgins 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 66</p> <p>Cont.: 68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0020" title="KrookJE , O'ConnellMJ , WieandHS , BeartRWJr , LeighJE , KuglerJW , et al. A prospective, randomized evaluation of intensive‐course 5‐fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer1991;67(10):2454‐8. ">Krook 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 61</p> <p>Cont.: 64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0022" title="LiseM , NittiD , MarchetA , SahmoudT , BuyseM , DuezN , et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. Journal of Clinical Oncology1995;13(11):2757‐63. ">Lise 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 155</p> <p>Cont.: 159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0023" title="MacdonaldJS , FlemingTR , PetersonRF , BerenbergJL , McClureS , ChapmanRA , et al. Adjuvant chemotherapy with 5‐FU, adriamycin, and mitomycin‐C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Annals of Surgical Oncology1995;2(6):488‐94. ">Macdonald 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 93</p> <p>Cont.: 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0024" title="NakajimaT , NashimotoA , KitamuraM , KitoT , IwanagaT , OkabayashiK , et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plustegafur in serosa‐negative gastric cancer: a randomised trial. Lancet1999;354(9175):273–7. ">Nakajima 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 288</p> <p>Cont.: 285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0025" title="NakajimaT , KinoshitaT , NashimotoA , SairenjiM , YamaguchiT , SakamotoJ , et al. Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa‐negative, locally advanced gastric cancer. British Journal of Surgery2007;94(12):1468–76. ">Nakajima 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 93</p> <p>Cont.: 95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0026" title="NashimotoA , NakajimaT , FurukawaH , KitamuraM , KinoshitaT , YamamuraY , et al. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa‐negative gastric cancer: Japan Clinical Oncology Group 9206‐1. Journal of Clinical Oncology2003;21(12):2282‐7. ">Nashimoto 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 127</p> <p>Cont.: 123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0027" title="NeriB , CiniG , AndreoliF , BoffiB , FrancesconiD , MazzantiR , et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5‐year follow‐up. British Journal of Cancer2001;84(7):878–80. ">Neri 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 69</p> <p>Cont.: 68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0028" title="NittiD , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Annals of Oncology2006;17(2):262–9. ">Nitti 2006 EORTC</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 103</p> <p>Cont.: 103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0029" title="NittiJ , WilsJ , Dos SantosJG , FountzilasG , ContePF , SavaC , et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCGD. Annals of Oncology2006;17:262–9. ">Nitti 2006 ICCG</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 91</p> <p>Cont.: 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0032" title="PopielaT , KuligJ , CzuprynaA , SzczepanikAM , ZembalaM . Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer2004;7:240–5. ">Popiela 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 53</p> <p>Cont.: 52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>?</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NR</p> <p>NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD008415-bbs2-0033" title="SakuramotoS , SasakoM , YamaguchiT , KinoshitaT , FujiiM , NashimotoA , et al. Adjuvant chemotherapy for gastric cancer with S‐1, an oral fluoropyrimidine. New England Journal of Medicine2007;357(18):1810‐20. ">Sakuramoto 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interv.: 517</p> <p>Cont.: 526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> <p>16</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Interv.: Intervention group (postsurgical chemotherapy).</p> <p>Cont.: Control group (surgery alone).</p> <p>NR: not reported.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Adverse effects</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/full#CD008415-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008415-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Post‐surgical chemotherapy versus surgery alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overal Survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.80, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disesase free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.72, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Post‐surgical chemotherapy versus surgery alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008415-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Chemobased OS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.84, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 5‐FU based chemotherapy OS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5694</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.83, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Platinum‐based chemotherapy OS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.81, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Stage OS analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.66, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 T1/2 OS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.71, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 T3/4 OS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.41, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Lymph node mets analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.68, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 N‐ OS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.41, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 N+ OS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.67, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Chemobased DFS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3913</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.79, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 5‐FU based chemotherapy DFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2944</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.78, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Platinum‐based chemotherapy DFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.75, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Low Risk of Bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.79, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.74, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 No allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.79, 0.93]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008415.pub2/references#CD008415-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008415.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008415-note-1206">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD008415-note-1205">Français</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD008415-note-1207">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008415\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008415\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008415\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008415\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008415\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008415.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008415.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008415.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008415.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008415.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716910015"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008415.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716910019"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008415.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dab056d8ef3f1',t:'MTc0MDcxNjkxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 